For this article:

20 Dec 2025·Source: The Indian Express
3 min
Social IssuesPolity & GovernanceInternational RelationsEXPLAINED

US Reclassifies Cannabis: A Global Shift in Drug Policy

US reclassifies cannabis, signaling a major shift in global drug policy and legalisation efforts.

US Reclassifies Cannabis: A Global Shift in Drug Policy

Photo by Linoleum Creative Collective

Background Context

The CSA of 1970 placed cannabis in Schedule I, defining it as having high abuse potential and no accepted medical use. This classification has historically driven the "war on drugs" and led to severe federal penalties. The UN's 2020 decision to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs also set a precedent for acknowledging its medical utility.

Why It Matters Now

This reclassification by the US is a major policy shift that could have profound implications for federal law enforcement, medical research, and the burgeoning cannabis industry. It also puts pressure on international drug control treaties and other nations to reconsider their own cannabis policies.

Key Takeaways

  • •Understand the difference between Schedule I and Schedule III classifications.
  • •Recognize the historical context of cannabis prohibition in the US.
  • •Analyze the potential domestic impacts (research, federal penalties, state laws).
  • •Consider the international implications for drug control and diplomacy.

Different Perspectives

  • •Proponents argue it's a step towards evidence-based drug policy, promoting medical research and reducing criminalization.
  • •Opponents express concerns about potential public health risks, increased substance abuse, and the impact on youth.
  • •Some advocates argue it doesn't go far enough, pushing for full federal legalisation.

Related Concepts

Controlled Substances ActInternational Drug Control Treaties (1961 Single Convention)Drug Legalisation vs. DecriminalisationPublic Health PolicyCriminal Justice Reform

The US government, under President Trump, has reclassified cannabis from a Schedule I to a Schedule III controlled substance. This move acknowledges its medical utility and lower abuse potential, aligning it with drugs like ketamine and anabolic steroids. This is a significant shift from its previous classification alongside heroin and LSD, which had no accepted medical use.

The reclassification could ease research, reduce federal penalties, and potentially influence international drug treaties, pushing a global trend towards cannabis legalisation and medical use. This decision, driven by a recommendation from the Department of Health and Human Services, marks a pivotal moment in drug policy, potentially impacting public health, criminal justice, and the economy.

Key Facts

1.

US reclassified cannabis from Schedule I to Schedule III

2.

Schedule I includes drugs like heroin and LSD (high abuse potential, no medical use)

3.

Schedule III includes drugs like ketamine and anabolic steroids (moderate to low abuse potential, accepted medical use)

4.

The reclassification was recommended by the Department of Health and Human Services

5.

The UN Commission on Narcotic Drugs removed cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs in 2020

6.

The 1961 Single Convention on Narcotic Drugs classifies cannabis as a dangerous drug

7.

The US Controlled Substances Act (CSA) of 1970 placed cannabis in Schedule I

8.

President Richard Nixon declared a "war on drugs" in 1971

9.

President Bill Clinton signed the Violent Crime Control and Law Enforcement Act in 1994

10.

More than 20 states have fully legalized recreational cannabis

11.

38 states have legalized medical cannabis

UPSC Exam Angles

1.

Impact on international drug control treaties and India's position.

2.

Implications for India's Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, and the debate around cannabis legalization/medical use in India.

3.

Public health considerations: potential medical benefits vs. risks of abuse, and harm reduction strategies.

4.

Criminal justice reform: potential for reduced federal penalties and decriminalization efforts.

5.

Economic implications: growth of legal cannabis industry, tax revenues, and impact on illicit markets.

Visual Insights

US Cannabis Policy: From Prohibition to Federal Reclassification (2012-2025)

This timeline highlights key milestones in US cannabis policy, illustrating the gradual shift from strict federal prohibition towards medical and regulatory acceptance, culminating in the 2025 reclassification.

The US federal stance on cannabis has been increasingly challenged by state-level legalizations and evolving scientific evidence. The HHS recommendation in 2023 was a pivotal moment, culminating in the 2025 reclassification, signaling a major shift from decades of strict prohibition and aligning federal policy more closely with medical understanding.

  • 2012Colorado & Washington become first US states to legalize recreational cannabis.
  • 2014Cole Memorandum (Obama admin) advises federal non-interference in state-legal cannabis operations.
  • 2018US Farm Bill federally legalizes hemp (cannabis with <0.3% THC), distinguishing it from marijuana.
  • 2019WHO recommends rescheduling cannabis under the UN Single Convention on Narcotic Drugs 1961.
  • 2020-2024Several more US states legalize medical and/or recreational cannabis; growing federal pressure for reform.
  • 2023US Department of Health and Human Services (HHS) recommends rescheduling cannabis to DEA.
  • 2025US government (under President Trump) reclassifies cannabis from Schedule I to Schedule III.

Practice Questions (MCQs)

1. Consider the following statements regarding the international drug control regime and cannabis: 1. The UN Single Convention on Narcotic Drugs, 1961, classifies cannabis as a Schedule IV drug, indicating its high abuse potential and limited medical use. 2. The recent reclassification of cannabis by the US government from Schedule I to Schedule III directly alters its status under the UN international drug control treaties. 3. India's Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, prohibits the cultivation, production, possession, sale, purchase, transport, storage, and/or consumption of cannabis, including 'bhang'. Which of the statements given above is/are correct?

  • A.1 only
  • B.2 and 3 only
  • C.1 and 3 only
  • D.None of the above
Show Answer

Answer: D

Statement 1 is incorrect. The UN Single Convention on Narcotic Drugs, 1961, lists cannabis in Schedule I and Schedule IV. Schedule IV is for drugs with particularly dangerous properties and limited therapeutic utility, but cannabis was moved out of Schedule IV by the UN Commission on Narcotic Drugs in 2020, while remaining in Schedule I. Statement 2 is incorrect. The US reclassification is a domestic policy change and does not directly alter the classification of cannabis under international UN treaties, though it may influence future discussions and reforms. Statement 3 is incorrect. The NDPS Act, 1985, differentiates between various parts of the cannabis plant. While 'ganja' (flowering/fruiting tops) and 'charas' (resin) are prohibited, 'bhang' (leaves) is explicitly excluded from the definition of 'cannabis' under the Act and is thus not prohibited.

2. In the context of the US reclassification of cannabis, which of the following statements correctly describes the implications of moving a substance from Schedule I to Schedule III under the US Controlled Substances Act?

  • A.Schedule I substances have accepted medical use and low abuse potential, while Schedule III substances have no accepted medical use and high abuse potential.
  • B.Reclassification to Schedule III will lead to immediate federal legalization of recreational cannabis use across all US states.
  • C.Schedule III classification acknowledges accepted medical utility and lower abuse potential, potentially easing research and reducing federal penalties.
  • D.The reclassification primarily affects state-level regulations, leaving federal laws largely unchanged regarding cannabis.
Show Answer

Answer: C

Option A is incorrect. Schedule I substances, like heroin and LSD, are defined as having no accepted medical use and a high potential for abuse. Schedule III substances, like ketamine and anabolic steroids, have accepted medical use and a moderate to low potential for physical and psychological dependence. Option B is incorrect. Reclassification to Schedule III does not equate to federal legalization of recreational use. It acknowledges medical utility and lowers the federal risk profile, but recreational use would still be federally prohibited. Option C is correct. Moving cannabis to Schedule III signifies an acknowledgment of its medical utility and a lower abuse potential compared to Schedule I. This change is expected to ease federal restrictions on research and potentially lead to reduced federal penalties for cannabis-related offenses. Option D is incorrect. The reclassification is a federal action and primarily impacts federal laws and regulations, though it will have ripple effects on state-level dynamics and enforcement.

3. Which of the following statements is NOT correct regarding the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, in India?

  • A.The Act was enacted to fulfill India's obligations under the UN Single Convention on Narcotic Drugs, 1961.
  • B.It provides for the cultivation of cannabis for industrial purposes, such as for obtaining fibre or seed, with due permission from the state government.
  • C.The Act makes no distinction between 'ganja' and 'bhang' in terms of prohibited substances and penalties.
  • D.The Narcotics Control Bureau (NCB) is the apex body for coordinating drug law enforcement in India under this Act.
Show Answer

Answer: C

Option A is correct. The NDPS Act, 1985, was indeed enacted to consolidate and amend the law relating to narcotic drugs and psychotropic substances and to fulfill India's international obligations. Option B is correct. Section 14 of the NDPS Act allows for the cultivation of cannabis for industrial purposes (e.g., for obtaining fibre or seed) or for horticultural purposes, with general or special orders of the state government. Option C is incorrect. The NDPS Act explicitly differentiates between 'ganja' (flowering/fruiting tops of the cannabis plant, which is prohibited) and 'bhang' (leaves of the cannabis plant, which are excluded from the definition of 'cannabis' and thus not prohibited under the Act). This distinction is crucial. Option D is correct. The Narcotics Control Bureau (NCB) was constituted in 1986 under the NDPS Act to coordinate actions against drug trafficking and abuse.

GKSolverToday's News